Mr. Speaker, I am pleased to debate this motion which was first put before the House in 1997. I say to the member opposite who moved the motion that a lot has happened since then.
I welcome this opportunity to speak about this very important issue and remind the House of the leadership taken by the federal government and in particular the Minister of Health regarding the issue of hepatitis C.
Without question the plight of Canadians who contracted hepatitis C from the blood supply evokes in all of us an overwhelming impulse of concern and sympathy. People who were injured or ill and who needed blood transfusions turned to our blood system in their time of need. Mr. Justice Krever so ably described in his final report that the blood system served to compound their problems because the blood they received was infected with hepatitis C.
In 1998 federal, provincial and territorial ministers of health put $1.1 billion on the table to settle lawsuits and legal claims for the period between 1986 and 1990. We know from the debate which took place in the House the reason for that time period. There was an acknowledgement both in Mr. Justice Krever's report and among public policy experts in Canada that had different decisions been made in 1986, there might have been a different result. We know that it is always hard to judge those issues, but decisions were made in Canada, decisions were taken in Canada that were different from the international standard that had been established in 1986.
This past December an agreement in principle was reached by the negotiators. I understand that significant progress is being made to finalize the settlement proposal which will go before the courts for approval. That is enormous progress on this very difficult and important issue. We believe that whatever settlement is proposed, it is the courts that must say that this is fair. That is the foundation of the policy of the government, one of fairness and one of compassion.
Whatever the specifics of the emerging settlement, the government is confident that these negotiations have been the appropriate way to proceed, given that these matters have to be resolved before the courts and Canadians want a full, comprehensive and responsible solution to this issue.
I have had the privilege of serving in public office for almost 20 years, at the provincial level for 12 years, five of those in government, seven in opposition. I say to members opposite that being in opposition affords them a certain luxury of being irresponsible. But being in government, good public policy requires that governments be responsible in the decisions they propose. I believe the government has been responsible and compassionate in its approach on this issue.
Within the Canadian tradition of moderate compromise, we will solve in a responsible way the difficult issues of the past as they relate to hepatitis C.
At the end of the day, this negotiated settlement should in financial terms give a measure of comfort to many of the individuals who were infected with hepatitis C by the blood system.
But the federal government has had to take a longer and broader view. Hepatitis C is still a relatively new disease to the scientific and medical communities. The federal government has taken decisive action.
This past September the Minister of Health announced a comprehensive federal initiative including funding for medical research, community support, public education, improvements in disease surveillance and to work to find those who might not yet know they are infected with hepatitis C. The Minister of Health announced a proposal to the provinces and the territories for a significant transfer payment to be made to ensure that the health system in each of the provinces responds as fast as it can and as appropriately as it can to the health needs of those infected.
This has not been an easy path. We should not forget that it took federal leadership to have this issue receive the attention it has received to where we are today which is trying to settle those lawsuits between 1986 and 1990 and provide health services to those who were infected outside of that window where if other decisions had been made, perhaps the outcomes and the results would have been different.
Federal investment in hepatitis C is now very significant, in all totalling more than $1 billion, but it is not only money that measures the level of federal commitment in this area. It is also what these initiatives represent in terms of the commitment to knowledge and scientific development and fostering new productive relationships, all the while preserving and respecting the federal role in health and health care.
I would like to take the next few minutes to review some of those successes in addressing the hepatitis C issue that the federal leadership has brought about in just a few short years. While we all acknowledge that there are things yet to be done, we do not spend enough time acknowledging that which has been done.
First let me start by pointing out that as in all things Canadian, this issue has required interjurisdictional collaboration. Federal, provincial and territorial governments have worked closely with one another to see that the transition to a new blood system, one that Canadians can have confidence in, has gone as smoothly as possible and that blood and blood products in Canada are as safe as they can be.
For its part, the federal government has had a leading role in what has been a very successful transition. A key part has been to ensure that all jurisdictions are of the same frame of mind when it comes to making the safety of the blood system paramount. That is a huge accomplishment. That is a significant and important change.
The additional $125 million in support of the federal regulatory and disease surveillance role, and up to $50 million to help the provinces pay for their public health function of finding those people who are infected with hepatitis C are clear indications of the federal government's commitment to ensuring that these functions are sufficiently resourced.
The federal government has acknowledged that people infected with hepatitis C might not always have reasonable access to the health services they might require over time, and that increasing resources would help to address this problem. The Minister of Health has offered $300 million to the provinces and territories as a way to cover the needed medical care over the next 20 years and to focus our attention on resolving the issues surrounding this disease. The provinces and the territories have yet to fully respond.
We have also moved to meet the needs for more information and more support. We could not wait until the research momentum had built up by itself. For that reason the federal Minister of Health announced dedicated research funding of up to $50 million over the next five years because we need answers if we are going to help those people.
I am pleased to report that the federal government has been funding efforts to educate medical professionals and the public about hepatitis C. All these indications suggest that our efforts are working.
Finally, we know many people who suffer with disabilities apply for the Canada pension plan as an important source of income. There are people with all kinds of disabilities. We all know from our constituency work that the process of determining eligibility through the Canada pension plan disability benefit is very thorough. That means it is difficult.
CPP adjudicators look at each case to determine if the disability genuinely prevents the person from working at any job. To ensure that adjudicators are aware of hepatitis C, its implications and its impact, Human Resources Development Canada has carried out very specific training for the adjudicators. People with hepatitis C over the years will now have adjudicators who are responsive and sensitive and who understand hepatitis C. That is something we do not talk about, but it is very important.
These are the types of activities that require the kind of commitment we have seen from the federal government. Without this commitment there would not be the momentum behind the comprehensive approach to dealing with hepatitis C that we see today.
The last word I would like to make today on this important motion is that the action taken by the federal government is not only appropriate and good public policy, it was the right thing to do.